David Collier
Algemeen Directeur bij Velocity Pharmaceutical Development LLC
Oorsprong van het eerstegraads netwerk van David Collier
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 13 | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.
9
| Private Company | Investment Managers | 9 |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA.
9
| Subsidiary | Drugstore Chains | 9 |
X-37 Service Co., Inc.
 X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California.
4
| Private Company | Investment Managers | 4 |
Reeve Foundation - Presidio Partners NRT LP
 Reeve Foundation - Presidio Partners NRT LP Investment ManagersFinance Reeve Foundation - Presidio Partners NRT LP is a special purpose vehicle formed to invest in NeuroRecovery Technologies Inc.
3
| Venture Capital Fund | Investment Managers | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Collier via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree | |
| JPMORGAN CHASE & CO. | Major Banks | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
| ACUSPHERE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Spitfire Pharma, Inc.
 Spitfire Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Spitfire Pharma, Inc. provides drug development and research services. The firm’s products include SP-1373, a potent GLP-1/Glucagon receptor co-agonist for the treatment of non-alcoholic steatohepatitis. The company was founded by John J. Nestor, Jr. and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | President Chief Executive Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Graduate Degree | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
| Union College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Investment Managers | Founder Private Equity Investor | |
Life Science Angels
 Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California. | Investment Managers | Investment Committee Member Private Equity Investor | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Malaysian Life Sciences Capital Fund Management Co. Ltd.
 Malaysian Life Sciences Capital Fund Management Co. Ltd. Investment ManagersFinance Malaysian Life Sciences Capital Fund Management Co Ltd (MLSCFM) is a venture capital firm founded in 2006. The firm is headquartered in Kuala Lumpur, Malaysia. | Investment Managers | Chairman Private Equity Investor | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kenan-Flagler Business School | College/University | Undergraduate Degree Masters Business Admin | |
Velocity Pharmaceutical Holdings LLC
 Velocity Pharmaceutical Holdings LLC Financial ConglomeratesFinance Velocity Pharmaceutical Holdings LLC operates as a holding American company. | Financial Conglomerates | Founder Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
BAR Capital Management LLC
 BAR Capital Management LLC Investment ManagersFinance BAR Capital Management LLC is a private equity/venture capital firm founded in 2005 by Roger E. Wyse. The firm is headquartered in Woodside. | Investment Managers | Corporate Officer/Principal Founder | |
Atomwise, Inc.
 Atomwise, Inc. Medical DistributorsDistribution Services Atomwise, Inc. develops artificial intelligence systems. It specializes in drug discovery and machine learning. The company was founded by Abraham Heifets, Izhar Wallach and Alexander Levy and is headquartered in Wilmington, DE. | Medical Distributors | Director/Board Member Founder | |
Corsair Pharma, Inc.
 Corsair Pharma, Inc. BiotechnologyHealth Technology Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| DESIGN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Avestria Ventures Management, LLC
 Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
CMEA Capital
 CMEA Capital Financial ConglomeratesFinance CMEA Capital is an American venture capital company. The private company was founded by Thomas R. Baruch. | Financial Conglomerates | Director of Finance/CFO Director of Finance/CFO | |
Avanea Energy Acquisition Corp.
 Avanea Energy Acquisition Corp. Financial ConglomeratesFinance Avanea Energy Acquisition Corp. operates as a blank check company. It is formed for the purpose of affecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on March 4, 2021 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Inobat Auto
 Inobat Auto Electrical ProductsProducer Manufacturing Inobat Auto is a European-based battery manufacturer that provides innovative solutions across the entire value chain with a "cradle-to-cradle" approach, showcasing the concept of a circular economy. The private company is based in Bratislava, Slovakia. The Slovak company specializes in the research, development, manufacture, and provision of premium innovative electric batteries custom-designed to meet the specific requirements of mainstream and specialist OEMs within the automotive, commercial vehicle, motorsport, and aerospace sectors. Inobat Auto is backed by a strong consortium of investors and technology companies, including lead investor IPM Group. The company has a battery research and development facility and pilot line under development in Slovakia. | Electrical Products | Chairman Director/Board Member | |
Our Next Energy, Inc.
 Our Next Energy, Inc. Electrical ProductsProducer Manufacturing Our Next Energy, Inc. is a Michigan-based energy storage technology company that focuses on engineering batteries to accelerate electrification in transportation and stationary applications. The company is based in Novi, MI. The company's vision is to double the range of electric vehicles, use safer and more sustainable raw materials, and establish a localized supply chain. The company was founded in 2021 by Mujeeb I. Ijaz, who has been the CEO since then. | Electrical Products | Director/Board Member Director/Board Member | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Finland | 2 |
| Canada | 2 |
| Maleisië | 2 |
| Verenigde Arabische Emiraten | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 13 |
| Finance | 13 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
Operationeel
| Director/Board Member | 299 |
| Corporate Officer/Principal | 110 |
| Private Equity Investor | 53 |
| Founder | 46 |
| Independent Dir/Board Member | 44 |
Sterkste connecties
| Insiders | |
|---|---|
| Faysal Sohail | 34 |
| Evan S. Melrose | 32 |
| Michael Grey | 32 |
| Samuel Saks | 28 |
| Peter Gajdos | 26 |
| Roger E. Wyse | 26 |
| Ann Hanham | 26 |
| John Schmid | 24 |
| James Watson | 24 |
| Bharatt Chowrira | 24 |
| Bryant Fong | 23 |
| Gaurav Aggarwal | 21 |
| Antoine Blondeau | 20 |
| Kiersten Stead | 20 |
| Brett Cummings | 20 |
- Beurs
- Insiders
- David Collier
- Bedrijfsconnecties
